To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes.
TQL analysis
Not yet gradedThis bill has no published Quiet Ledger grade yet.
Legislative structure
Criterion breakdown8 criteria · max 90
No grade to break down.Actions (4)
| Date | Time | Action |
|---|---|---|
| 2020-03-03 | — | Referred to the House Committee on Energy and Commerce. |
| 2020-03-03 | — | Introduced in House |
| 2020-03-03 | — | Introduced in House |
| 2020-03-04 | — | Sponsor introductory remarks on measure. (CR H1476) |
The Quiet Ledger grades legislation on its content. A bill grade is analysis of the bill — not a grade of its sponsor or of any member who voted on it.